© Reuters. FILE PHOTO: Vials of Oxford/AstraZeneca’s COVID-19 vaccine are pictured at a vaccination centre in Bierset, Belgium March 17, 2021. REUTERS/Yves Herman
BRUSSELS (Reuters) – A second legal case brought by the European Commission against AstraZeneca (NASDAQ:) over its delayed delivery of COVID-19 vaccines got underway in a Brussels court on Tuesday.
Officials familiar with the case said the lawsuit is mostly procedural – pertaining to the merits of the issue – after a first case was launched in April, and would allow the European Union to seek possible financial penalties.
The first legal action was about requesting faster deliveries, whereas the new one will concern the merit of the case.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.